News and reflections from the world of AI

Employee Spotlight: Interview with Dr. Lindsey Smith

Describe your role at Aiforia. My current role at Aiforia is multifaceted and highly exciting. I primarily train our customers on how to use our platform to build their own custom AI models, which have a wide range of complexity and applications. My role implements various skills including customer support, data analysis, building and troubleshooting AI models with the platform, procuring ...

Aiforia and CompuMed collaborate to enhance organ transplant pathology with AI

CompuMed and its team of highly experienced physicians provide specialized diagnostic interpretations to their clients who need answers in high urgency situations. Organ Procurement Organizations (OPOs) which provide organs and tissue for transplant centers need critical information relating to for example pathology, cardiology, or radiology to improve donor management, decrease donor evaluation ...

AI in toxicologic pathology: an overview

Toxicologic Pathology Toxicologic pathology, the study of chemicals’ adverse effects on animal models of human diseases, has a significant use in preclinical drug assessment. Toxicologic pathologists are crucial for drug discovery and chemical safety assessments due to their skills in informational interpretation from a broad range of disciplines. This is particularly relevant for the various ...

Interview with Pathologist, Dr. Nelli Sjöblom, on AI models aiding chronic cholestasis detection

A cholestatic condition is characterised by a decrease in bile flow as substances normally excreted into bile are retained. Often this is due to impaired hepatocytes or obstruction of bile ducts caused by primary damage to the biliary epithelium.

Introduction to tCECs: a novel method for cancer diagnostics

Cancer Diagnostics Expedited by the COVID-19 pandemic and the disruption it caused to healthcare systems, cancer rates are rising worldwide. Yet, diagnostic methods are finding it difficult to keep up.

Doctoral student Polina Stepanova discusses benefits of AI in Huntington's Disease image analysis

What is Huntington's Disease? Huntington's disease (HD) is a progressive brain disorder caused by a single defective gene, called huntingtin. Over time this leads to brain damage that causes symptoms such as abnormal involuntary movements, severe cognitive decline, and mood changes. As a dominant genetic defect, anyone who inherits it will eventually develop the disease and there is currently no ...